CompletedNot Applicable

The Memorial Sloan-Kettering Cancer Center (MSKCC

France3,194 participantsStarted 2011-12

Plain-language summary

The purpose of this study is to prospectively evaluate the combined use of the MSKCC nomogram (Memorial Sloan-Kettering Cancer Center) and Tenon score to select, in patients with metastatic sentinel lymph node (SN), those at low risk of metastatic non-SN in whom additional axillary lymph node dissection (ALND) could be avoided.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged over 18 years old with invasive breast cancer with an indication of SN procedure as recommended by Saint-Paul de VENCE in 2005 amended in 2009 * T1-2 breast cancer * Patients having social security coverage. Exclusion Criteria: * Patient under the age of 18. * Patient who had neoadjuvant chemotherapy. * Patient who had had radiotherapy to the ipsilateral axilla or breast. * Pregnant patient. * Patients who do not speak French. * Patients refusing to participate in the study. * Simultaneous participation in another research period of exclusion

What they're measuring

False negative rate in patients with both a ≤ 10% probability of metastatic non-SN with the MSKCC nomogram and a Tenon score ≤ 3.5 (i.e. low risk): proportion of patients with metastatic non-SN at additional ALND.

Timeframe: after the surgery

Trial details

NCT IDNCT01509963

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-07

View on ClinicalTrials.gov More Breast Cancer trials